Documented Review of Therapeutic Response in 6 Months for Antipsychotic Prescribing for BPSD
Identifying Attributes
Care Settings
Country
Publishing Organisation
Type of Quality Indicator
IOM Quality Dimension
Domain
Defining Attributes
Definition
Documented review of therapeutic response in 6 months for antipsychotic prescribing for BPSD
Numerator
Number of patients having a documented medication review in the previous 6 months addressing therapeutic response
Denominator
Number of patients patients with a diagnosis of dementia AND with no comorbid psychotic disorder who had been prescribed an antipsychotic for at least 6 months
Exclusions
Patients with comorbid psychotic illness
Use of Risk Adjustment
Risk Adjustments
Stratifications
Collection and Reporting Attributes
Type of Data Collection
Data Collection Methods
Through audit-based, quality improvement programme (QIP) which focus on the prevalence and quality of antipsychotic prescribing in people with dementia and is part of the College Centre for Quality Improvement (CCQI) at the UK Royal College of Psychiatrists
Frequency of Data Collection
Frequency of Data Collection in Days
Reporting Methods
Peer-reviewed papers and reports
Reporting Frequency
Reporting Frequency in Days
Indicator Has Recommended Targets
Source and Reference Attributes
Evidence Source
Barnes, T. R. E., Banerjee, S., Collins, N., Treloar, A., McIntyre, S. M., & Paton, C. (2012). Antipsychotics in dementia: prevalence and quality of antipsychotic drug prescribing in UK mental health services. The British Journal of Psychiatry, 201(3), 221-226 The Prescribing Observatory for Mental Health 15-year report, CCQI 353, 2020, The Royal College of Psychiatrists
Technical Specifications
Link to Measurement Tools
Swedish Register of Palliative Care Survey